Search research articles
Contact Us
Filters
Showing results (91-100 of 186) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study
Yael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group
Brigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Cancer Chemotherapy and Pharmacology
|
January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Elizabeth Fox, John M Maris, Susan L Cohn, et al.
Cancer
|
April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma
Kristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Cancer
|
November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)
James I Geller, Elizabeth Fox, Brian K Turpin, et al.
Plos One
|
November 13, 2015
A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy
Serena P Koenig, Alexandra Bornstein, Karine Severe, et al.
British Journal of Haematology
|
March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)
Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group
Shana Jacobs, Elizabeth Fox, Mark Krailo, et al.
Pediatric Blood & Cancer
|
January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Cold Spring Harbor Molecular Case Studies
|
October 28, 2022
Discovery and functional characterization of the oncogenicity and targetability of a novel <i>NOTCH1-ROS1</i> gene fusion in pediatric angiosarcoma
Payal Jain, Sudarshan Iyer, Joshua Straka, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 186) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study
Yael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.
Pediatric Blood & Cancer
|
September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group
Brigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Cancer Chemotherapy and Pharmacology
|
January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Elizabeth Fox, John M Maris, Susan L Cohn, et al.
Cancer
|
April 20, 2023
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma
Kristina A Cole, Heba Ijaz, Lea F Surrey, et al.
Cancer
|
November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)
James I Geller, Elizabeth Fox, Brian K Turpin, et al.
Plos One
|
November 13, 2015
A Second Look at the Association between Gender and Mortality on Antiretroviral Therapy
Serena P Koenig, Alexandra Bornstein, Karine Severe, et al.
British Journal of Haematology
|
March 16, 2017
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)
Susan R Rheingold, Sarah K Tasian, James A Whitlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group
Shana Jacobs, Elizabeth Fox, Mark Krailo, et al.
Pediatric Blood & Cancer
|
January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors
Kristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
Cold Spring Harbor Molecular Case Studies
|
October 28, 2022
Discovery and functional characterization of the oncogenicity and targetability of a novel <i>NOTCH1-ROS1</i> gene fusion in pediatric angiosarcoma
Payal Jain, Sudarshan Iyer, Joshua Straka, et al.
Page
of 19